These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2978804)
1. Lipoprotein (a) as a risk factor for atherosclerotic diseases. Dahlén G Arctic Med Res; 1988; 47 Suppl 1():458-61. PubMed ID: 2978804 [No Abstract] [Full Text] [Related]
2. [Lipoprotein(a) as a risk factor for arteriosclerosis]. Steinmetz A; Utermann G Internist (Berl); 1992 Jan; 33(1):24-31. PubMed ID: 1532383 [No Abstract] [Full Text] [Related]
3. The optimal low-density lipoprotein is 50 to 70 mg/dl. Clendenning R J Am Coll Cardiol; 2005 May; 45(10):1732; author reply 1732. PubMed ID: 15893199 [No Abstract] [Full Text] [Related]
4. [Lipoprotein Lp(a) as a risk factor for heart infarct--a family study]. Klein G; Brugger P; Kullich W; Marth E; Kostner GM Wien Med Wochenschr; 1984 Sep; 134(18):403-8. PubMed ID: 6239458 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Broeckel U; Hengstenberg C; Mayer B; Holmer S; Martin LJ; Comuzzie AG; Blangero J; Nürnberg P; Reis A; Riegger GA; Jacob HJ; Schunkert H Nat Genet; 2002 Feb; 30(2):210-4. PubMed ID: 11818963 [TBL] [Abstract][Full Text] [Related]
7. [Lipoprotein (a) and serum lipid levels young subjects with parents suffering from myocardial infarct]. Gaeta G; Cuomo S; Boeri F; Foglia MC; Iovine C; Boccalatte A G Ital Cardiol; 1996 Jul; 26(7):757-63. PubMed ID: 8964318 [TBL] [Abstract][Full Text] [Related]
8. Association of lipoprotein levels with atherosclerotic changes in patients with coronary artery spasm and insignificant coronary artery stenosis. Koh KK; Lee KH; Cho SK; Kim SS; Kim JJ; Lee YH Coron Artery Dis; 1995 Mar; 6(3):235-9. PubMed ID: 7788036 [TBL] [Abstract][Full Text] [Related]
9. New aspects in lipidology and atherosclerosis. Superko HR Can J Cardiol; 1995 May; 11 Suppl C():4C-8C. PubMed ID: 7750049 [TBL] [Abstract][Full Text] [Related]
10. Elevated lipoprotein (a) blood levels as the single treatable atherosclerotic risk factor in patients with coronary artery disease. Bays H; Dujovne CA; Mays JB J Ky Med Assoc; 1993 Nov; 91(11):498-500. PubMed ID: 8270845 [TBL] [Abstract][Full Text] [Related]
11. [Lipoprotein (a) in coronary heart disease and myocardial infarction]. Wottawa A; Fromme K; Klein G MMW Munch Med Wochenschr; 1984 Jan; 126(3):53-5. PubMed ID: 6230531 [No Abstract] [Full Text] [Related]
12. Lipoproteins in the progeny of young men with coronary artery disease: children with increased risk. Lee J; Lauer RM; Clarke WR Pediatrics; 1986 Aug; 78(2):330-7. PubMed ID: 3737309 [TBL] [Abstract][Full Text] [Related]
13. [Elevated levels of plasma von Willebrand factor: a new risk factor for atherosclerosis?]. Belicová M; Kubisz P; Kicko V; Dvorský J; Funiak S; Kvĕtenský J; Ivanková J Vnitr Lek; 1994 Oct; 40(10):660-2. PubMed ID: 7810085 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a): a hereditary risk factor for atherosclerotic disease. Donders SH; van Wersch JW Neth J Med; 1992 Feb; 40(1-2):96-104. PubMed ID: 1533703 [No Abstract] [Full Text] [Related]
15. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Healy AM; Pickard MD; Pradhan AD; Wang Y; Chen Z; Croce K; Sakuma M; Shi C; Zago AC; Garasic J; Damokosh AI; Dowie TL; Poisson L; Lillie J; Libby P; Ridker PM; Simon DI Circulation; 2006 May; 113(19):2278-84. PubMed ID: 16682612 [TBL] [Abstract][Full Text] [Related]
16. [Lipoprotein(a) [Lp(a)]--a genetically related risk factor for arteriosclerosis]. Feussner G; Feussner V; Ziegler R Med Klin (Munich); 1994 Apr; 89(4):198-203. PubMed ID: 8015535 [No Abstract] [Full Text] [Related]
17. Lipoprotein (a) and lipid levels in young patients with myocardial infarction and their first-degree relatives. Isser HS; Puri VK; Narain VS; Saran RK; Dwivedi SK; Singh S Indian Heart J; 2001; 53(4):463-6. PubMed ID: 11759936 [TBL] [Abstract][Full Text] [Related]
18. Lipoproteins, inflammatory biomarkers, and cardiovascular imaging in the assessment of atherosclerotic disease activity. Vanhecke TE; Franklin BA; Maciejko J; Chinnaiyan K; McCullough PA Rev Cardiovasc Med; 2009; 10(1):51-8. PubMed ID: 19367236 [TBL] [Abstract][Full Text] [Related]
19. Tissue factor and tissue factor pathway inhibitor levels in coronary artery disease: correlation with the severity of atheromatosis. Lima LM; Sousa MO; Dusse LM; Lasmar MC; das Graças Carvalho M; Lwaleed BA Thromb Res; 2007; 121(2):283-7. PubMed ID: 17582470 [No Abstract] [Full Text] [Related]
20. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries]. Bukowska H Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]